JP2021509811A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021509811A5 JP2021509811A5 JP2020536979A JP2020536979A JP2021509811A5 JP 2021509811 A5 JP2021509811 A5 JP 2021509811A5 JP 2020536979 A JP2020536979 A JP 2020536979A JP 2020536979 A JP2020536979 A JP 2020536979A JP 2021509811 A5 JP2021509811 A5 JP 2021509811A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- preparation according
- prevent
- treat
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 6
- 241000894006 Bacteria Species 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 208000017667 Chronic Disease Diseases 0.000 claims 3
- 206010061218 Inflammation Diseases 0.000 claims 3
- 208000006011 Stroke Diseases 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 235000014655 lactic acid Nutrition 0.000 claims 3
- 239000004310 lactic acid Substances 0.000 claims 3
- 230000004770 neurodegeneration Effects 0.000 claims 3
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 230000003712 anti-aging effect Effects 0.000 claims 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 230000000968 intestinal effect Effects 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 208000001076 sarcopenia Diseases 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 230000035882 stress Effects 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 206010008190 Cerebrovascular accident Diseases 0.000 claims 1
- 201000011240 Frontotemporal dementia Diseases 0.000 claims 1
- 206010019196 Head injury Diseases 0.000 claims 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 241000186605 Lactobacillus paracasei Species 0.000 claims 1
- 208000019022 Mood disease Diseases 0.000 claims 1
- 206010060860 Neurological symptom Diseases 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 208000018839 Wilson disease Diseases 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 208000025698 brain inflammatory disease Diseases 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 230000006866 deterioration Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010014599 encephalitis Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 210000005027 intestinal barrier Anatomy 0.000 claims 1
- 230000007358 intestinal barrier function Effects 0.000 claims 1
- 230000008944 intestinal immunity Effects 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 201000010901 lateral sclerosis Diseases 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000006742 locomotor activity Effects 0.000 claims 1
- 230000007087 memory ability Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 208000005264 motor neuron disease Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000003387 muscular Effects 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 230000009223 neuronal apoptosis Effects 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 208000021090 palsy Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000001052 transient effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862614296P | 2018-01-05 | 2018-01-05 | |
| US62/614,296 | 2018-01-05 | ||
| PCT/CN2019/070494 WO2019134690A1 (en) | 2018-01-05 | 2019-01-04 | A novel lactic acid bacteria and its applications |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021509811A JP2021509811A (ja) | 2021-04-08 |
| JP2021509811A5 true JP2021509811A5 (https=) | 2022-01-06 |
| JP7309212B2 JP7309212B2 (ja) | 2023-07-18 |
Family
ID=67144146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536979A Active JP7309212B2 (ja) | 2018-01-05 | 2019-01-04 | 新規な乳酸菌およびその応用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11938156B2 (https=) |
| EP (1) | EP3735456B1 (https=) |
| JP (1) | JP7309212B2 (https=) |
| CN (1) | CN111868229B (https=) |
| ES (1) | ES2986025T3 (https=) |
| TW (1) | TWI705136B (https=) |
| WO (1) | WO2019134690A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110305821B (zh) * | 2019-08-28 | 2019-12-17 | 鲁东大学 | 副干酪乳杆菌配合car-t细胞治疗应用 |
| JP7195714B2 (ja) * | 2020-10-19 | 2022-12-26 | 曽根ファーム株式会社 | 炎症性腸疾患用組成物 |
| CN110892940A (zh) | 2019-11-20 | 2020-03-20 | 内蒙古伊利实业集团股份有限公司 | 副干酪乳杆菌k56在缓解肠道炎症方面的新应用 |
| AU2021291569A1 (en) * | 2020-06-16 | 2022-10-20 | Md Healthcare Inc. | Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from lactobacillus paracasei |
| CN114504599A (zh) * | 2020-11-16 | 2022-05-17 | 内蒙古伊利实业集团股份有限公司 | 副干酪乳杆菌et-22在抗衰老、提高先天免疫方面的新应用 |
| CN117860789A (zh) * | 2020-11-16 | 2024-04-12 | 内蒙古伊利实业集团股份有限公司 | 副干酪乳杆菌k56在抗衰老、提高先天免疫方面的新应用 |
| KR102606636B1 (ko) * | 2021-01-29 | 2023-11-29 | 주식회사 농협사료 | 근감소증 예방 또는 개선 효과를 갖는 바실러스 벨레젠시스 및 이의 용도 |
| CN113322213B (zh) * | 2021-07-09 | 2022-05-13 | 吉林大学 | 一种具有改善记忆障碍功能的副干酪乳杆菌Jlus66菌剂和应用 |
| KR20230085279A (ko) * | 2021-12-06 | 2023-06-14 | 엠테라파마 주식회사 | 락토바실러스 파라카제이 nk112, 실새삼 추출물 및 새삼 추출물을 포함하는 인지기능 및 장기능 장애의 예방 또는 치료용 조성물 |
| WO2024086963A1 (en) * | 2022-10-24 | 2024-05-02 | Bened Biomedical Co., Ltd. | Lactic acid bacterium and method for preventing or minimizing exercise-induced muscle damage |
| CN116064314B (zh) * | 2022-11-01 | 2024-05-31 | 江苏省农业科学院 | 一株副干酪乳杆菌及其在制备发酵黑莓汁中的应用 |
| CN116617273A (zh) * | 2023-07-13 | 2023-08-22 | 微康益生菌(苏州)股份有限公司 | 副干酪乳杆菌lc86在制备用于预防、缓解或治疗与衰老相关的肌肉萎缩的产品中的应用 |
| CN119950560A (zh) * | 2025-03-10 | 2025-05-09 | 杭州百芮生物科技有限公司 | 乳酸菌菌株组合物在制备用于舒缓情绪以及促进神经元生长的组合物中的应用 |
| CN120310715B (zh) * | 2025-06-18 | 2025-10-24 | 宁波大学 | 一株具有改善抑郁功效的益生菌及其微生态制剂和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH092959A (ja) | 1995-06-16 | 1997-01-07 | Yakult Honsha Co Ltd | ＩｇＥ抗体産生抑制剤および抗アレルギー剤 |
| WO2010103132A1 (es) * | 2009-03-10 | 2010-09-16 | Hero España, S.A. | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
| DK2411027T3 (en) * | 2009-03-25 | 2015-01-19 | Chr Hansen As | USING a probiotic ADJUSTING body weight |
| CN104673700A (zh) * | 2013-11-29 | 2015-06-03 | 晨晖生物科技股份有限公司 | 乳酸菌株及引物组 |
| JP6305085B2 (ja) | 2014-02-06 | 2018-04-04 | キヤノン株式会社 | Ｘ線撮影装置及びその制御方法 |
| KR102240196B1 (ko) * | 2014-03-24 | 2021-04-15 | 오츠카 세이야쿠 가부시키가이샤 | 신규한 락토바실러스 파라카세이 균주 |
| EP3067058A1 (en) * | 2015-03-13 | 2016-09-14 | Farmagens Health Care Srl | Biological composition based on engineered lactobacillus paracasei subsp. paracasei f19 for the biosynthesis of cannabinoids |
| ITUB20152376A1 (it) * | 2015-07-07 | 2017-01-09 | Alfasigma Spa | Lactobacillus paracasei per la produzione di acido linoleico coniugato, preparazioni nutrizionali e farmaceutiche che lo comprendono e loro uso |
| TWI592487B (zh) | 2016-10-05 | 2017-07-21 | 益福生醫股份有限公司 | 新穎副乾酪乳桿菌副乾酪亞種ｋ５６ |
| JP7303811B2 (ja) | 2017-12-19 | 2023-07-05 | デュポン ニュートリション バイオサイエンシーズ エーピーエス | 認知的及び精神的健康のためのプロバイオティクス |
-
2019
- 2019-01-04 US US16/959,891 patent/US11938156B2/en active Active
- 2019-01-04 ES ES19736090T patent/ES2986025T3/es active Active
- 2019-01-04 WO PCT/CN2019/070494 patent/WO2019134690A1/en not_active Ceased
- 2019-01-04 EP EP19736090.2A patent/EP3735456B1/en active Active
- 2019-01-04 TW TW108100458A patent/TWI705136B/zh active
- 2019-01-04 CN CN201980007490.9A patent/CN111868229B/zh active Active
- 2019-01-04 JP JP2020536979A patent/JP7309212B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021509811A5 (https=) | ||
| US11253556B2 (en) | Lactobacillus fermentum GKF3, composition comprising the strain and method for improving psychataxia using the same | |
| JP7070964B2 (ja) | 新規なキューティバクテリウムアビダム菌株、該菌株またはその培養物を含むアトピー皮膚炎予防または治療用組成物 | |
| CN109789173B (zh) | 源自芽孢杆菌细菌的纳米囊泡及其用途 | |
| JP2021509811A (ja) | 新規な乳酸菌およびその応用 | |
| JP2020505031A (ja) | 新規乳酸菌およびその応用 | |
| JP2020520911A5 (https=) | ||
| JP2024535901A (ja) | 新規プロバイオティクスおよびその用途 | |
| CN114540245A (zh) | 一株同时具有缓解抑郁情绪及促进肠道分泌IgA功能的鼠李糖乳杆菌CCFM1228及其应用 | |
| CN110643541B (zh) | 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用 | |
| WO2025030991A1 (zh) | 一种改善帕金森病的长双歧杆菌婴儿亚种及其应用 | |
| US20130309212A1 (en) | Lactobacillus salivarius and method for preparing metabolite thereof, composition of lactobacillus salivarius and metabolite thereof and use of the composition | |
| JP7498455B2 (ja) | ミトコンドリア機能改善剤 | |
| CN119391598A (zh) | 一种植物乳植杆菌yn-03及由其制备的产品和应用 | |
| JP5995593B2 (ja) | 抗炎症剤 | |
| US20240382539A1 (en) | Use of intestinal probiotic in preparation of medicament that promotes metabolism of ellagic acid into urolithin a, pharmaceutical composition and use thereof | |
| KR102333226B1 (ko) | 구강질환 예방 또는 치료용 프로바이오틱스 및 이를 포함하는 구강질환 예방 또는 개선용 식품 조성물 | |
| JP2022540576A (ja) | 細菌株を含む組成物 | |
| CN112546074B (zh) | 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用 | |
| JP5612870B2 (ja) | 褥瘡改善作用を有する組成物 | |
| US20250129327A1 (en) | Application of blautia sp b2132 strain in preventing and/or treating inflammatory bowel disease | |
| Mancuskova et al. | The medical functions of probiotics and their role in clinical nutrition | |
| Premkishore et al. | Effect of honey and aqueous ginger extract against Streptococcus mutans isolated from extracted carious deciduous teeth | |
| CN104031856B (zh) | 干酪乳杆菌及其应用以及功能食品组合物及其制备方法 | |
| CA3099880A1 (en) | Compositions comprising bacterial strains |